The use and resistance to antibiotics in the community

International Journal of Antimicrobial Agents

Volumn 21, Issue 4, 2003, Pages 297-307

  Čižman, Milan ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Escherichia coli; Moraxella catarrhalis; Streptococcus pneumoniae

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CLAVULANIC ACID; COTRIMOXAZOLE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; BACTERIUM ISOLATION; COMMUNITY; CORRELATION ANALYSIS; DATA ANALYSIS; DEVELOPED COUNTRY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; DRUG USE; ESCHERICHIA COLI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PEDIATRICS; PENICILLIN RESISTANCE; POLICY; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIA;

EID: 0037383006     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00394-1     Document Type: Review

References (96)

1. Wise R., Hart T., Cars O., et al. Antimicrobal resistance is a major threat to public health. Br. Med. J. 317:1998;609-610.
2. Sørensen T.L., Monnet D. Control of antibiotic use in the community: the Danish experience. Infect. Control Hosp. Epidemiol. 21:2000;387-389.
3. Bremon R.A., Ruiz-Tovar M., Gorricho P.B., Diaz de Torres P., Rodriguez R. Non-hospital consumption of antibiotics in Spain: 1987-1997. J. Antimicrob. Chemother. 45:2000;395-400.
4. Cars O., Mölstad S., Melander A. Variation in antibiotic use in European Union. Lancet. 357:2001;1851-1853.
5. Standing Medical Advisory Committee: Subgroup on Medical Resistance. The Path of Least Resistance. Department of Health: 1998. Available from http://www.doh.gov.uk/smac.htm .
6. Sullivan A., Edlund C., Nord C.E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1:2001;101-114.
7. Cunha B.A. Antibiotic resistance. Med. Clin. N. Am. 84:2000;1407-1429.
8. Ministry of Health, Ministry of Food, Agriculture and Fisheries. The Copenhagen Recommendations. Report from the Invitational EU Conference on the microbial threat. Copenhagen, Denmark September; 1998.
9. Edlund C., Nord C.E. The evaluation and prediction of the ecologic impact of antibiotics in human phase I and II trial. Clin. Microbiol. Infect. 7:(Suppl 5):2001;37-41.
10. Stratchounski L., Bedenkov A., Hryniewicz W., Krcmery V., Ludwig E., Semenov V. The usage of antibiotics in Russia and some countries in Eastern Europe. Int. J. Antimicrob. Agents. 18:2001;283-286.
11. Schito G.C., Delbia E.A., Marchese A. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J. Antimicrob. Chemother. 46:(Topic T 1):2000;3-9.
12. Sahm D.F., Jones M.E., Hickey M.L., Diakun D.R., Mani S.V., Thornsberry C. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J. Antimicrob. Chemother. 45:2000;457-466.
13. Perez-Trallero E., Fernandez-Mazarrasa C., Garcia-Rey C., et al. Antimicrobial susceptibilities of 1684 Streptococcus pneumoniae and 2039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob. Agents Chemother. 45:2001;3334-3340.
14. Verhaegen J., Van De Ven J., Verbist N., Van Eldere J., Verbist J. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium update (1994-1998). Clin. Microbiol. Infect. 6:2000;308-315.
15. Jacobs MR, Felmingham D, Appelbaum PC, Alexander Project group. The Alexander Project 1998; penicillin and macrolide resistance in 2675 isolates of Streptococcus pneumoniae from 15 countries on five continents. Abstract 1044. Abstract of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 1999.
16. Anon. Jarvanyugyi bakteriologiai halozat. 1998; 152.
17. Manninen R, Huovinen P, Nissinen A, The Finnish Study Group for Antimicrobial Resistance. Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland. J Antimicrob Chemother 1999;40:387-92.
18. Pihlajamäki M., Kotilainen P., Kaurila T., et al. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Clin. Infect. Dis. 33:2001;483-488.
19. Cizman M, Pokorn M, Paragi M, Slovenian Meningitis Study Group. Antimicrobial resistance of invasive Streptococcus pneumoniae in Slovenia from 1997-2000. J Antimicrob Chemother 2002;49:582-4.
20. Lindbaek M., Berild D., Straand J., Hjortdahl P. Influence of prescription patterns in general practice on antimicrobial resistance in Norway. Br. J. Gen. Pract. 49:1999;436-440.
21. Leegaard T.M., Bevanger L., Jureen R., et al. Antibiotic sensitivity still prevails in Norweigan blood culture isolates. Int. J. Antimicrob. Agents. 18:2001;99-106.
22. Mölstad S., Cars O. Major change in the use of antibiotics following a national programme: Swedish strategic programme for the rational use of antimicrobial agents and surveillance of resistance (STRAMA). Scand. J. Infect. Dis. 31:1999;191-195.
23. Arendrup M., Knudsen J.D., Jensen E.T., Jensen I.P., Frimodt-Møller N. Prevalence of and detection of resistance to ampicillin and other β-lactam antibiotics in Haemophilus influenzae in Denmark. Scand. J. Infect. Dis. 33:2001;266-271.
24. Milatovic D, Verhoef J, Fluit AC. Prevalence and genotypes of macrolide resistant Streptococcus pneumoniae and beta-hemolytic streptococci in the Netherlands, Denmark and Luxembourg. Abstract C 140. Abstract of the 40th Interscience Conference of Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 2001.
25. Stratchounski L.S., Kretchiva O.I., Reshedko G.K., et al. Antimicrobial susceptibility of nasopharyngeal isolates of Haemophilus influenzae from healthy children in day-care centres: results of multicentre study in Russia. Internat J. Antimicrob. Agents. 18:2001;347-351.
26. Stratchounski L.S., Kretchiva O.I., Kozlov R.S., et al. Antimicrobial resistance of Streptococcus pneumoniae isolated from healthy children in day-care centers: results of a multicenter study in Russia. Pediatr. Infect. Dis. J. 19:2000;196-200.
27. Bruinsma N, Hutchinson JM, Giamarellou H et al. Importance of population density on the prevalence of antibiotic resistance in the fecal flora of healthy volunteeres. Abstract K 101. Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 2000.
28. Levy S.B. Antibiotic resistance: consequences of inaction. Clin. Infect. Dis. 33:(Suppl 3):2001;S124-S129.
29. Wise R, Andrews JM, Synercid resistance surveillance group. Local surveillance of antimicrobial resistance. Lancet 1998;352:657.
30. Livermore D.M., Stephens P., Weinberg J., et al. Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing. J. Antimicrob. Chemother. 46:2000;411-422.
31. Baquero F., Martinez-Belthran J., Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother. 28:(Suppl C):1991;31-38.
32. Baquero F. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J. Antimicrob. Chemother. 38:(Suppl A):1996;117-132.
33. Bronzwaer S.L.A.M., Cars O., Buchholz V., et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8:2002;278-282.
34. Garcia-Rey C., Aguilar L., Baquero F., Casal J., Dal Re R. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J. Clin. Microbiol. 40:2002;159-164.
35. Nissienen A., Grönroos P., Huovinen P., et al. Development of β-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin. Infect. Dis. 21:1995;1193-1196.
36. Nasrin D., Collignon P.J., Roberts L., Wilson E.J., Pilotto L.S., Douglas R.M. Effect of β lactam antibiotic use in children on pneumococcal resistance to penicillin prospective cohort study. Brit. Med. J. 324:2002;28-30.
37. Ghaffar F., Muniz L.S., Katz K., et al. Effects of amoxicillin/clavulanate or azythromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Clin. Infect. Dis. 31:2000;875-880.
38. Varon E., Levy C., De La Rocque F., et al. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in children with respiratory tract infection. Clin. Infect. Dis. 31:2000;477-481.
39. Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin. Infect. Dis. 32:2001;1044-1054.
40. Arason V.A., Kirstinsson K.G., Sigurdsson J.A., Stefansdolttir G., Mölstad S., Gudmundsson S. Do antimicrobial increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Brit. Med. J. 313:1996;387-391.
41. Melander E., Mölstad S., Persson K., Hansson H.B., Söderstation M., Ekdahl K. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur. J. Clin. Microbiol. Infect. Dis. 17:1998;834-838.
42. Seppäla H., Nissinen A., Järvinen N., et al. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:1992;292-297.
43. Perez-Trallero E., Urbieta M., Montes M., Ayestaran I., Marimon J.M. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur. J. Clin. Microbiol. Infect. Dis. 16:1998;25-31.
44. Cizman M., Pokorn M., Seme K., Paragi M., Orazem A. Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 18:1999;522-524.
45. Cizman M., Pokorn M., Seme K., Orazem A., Paragi M. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J. Antimicrob. Chemother. 47:2001;475-477.
46. Granizo J.J., Aguilar L., Casal J., Dal-Re R., Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J. Antimicrob. Chemother. 46:2000;959-964.
47. Cornaglia G., Ligozzi M., Mazzariol A., et al. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin. Infect. Dis. 27:(Suppl 1):1998;S87-S92.
48. Nielsen HUK, Monet DL, Sørensen DL, Kaltoft M, Konradsen HB, Frimoolt-Moller N. Relationship between antimicrobial use and rate of invasive erythromycin-resistant Streptococcus pneumoniae at county level. Abstract C2 1867. Abstracts of the 41th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 2001.
49. Reinert R.R., Al-Lahham A., Lemperle M., et al. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J. Antimicrob. Chemother. 49:2002;61-68.
50. DeNeeling A.J., Overbeek B.P., Horrevorts A.M., Ligtvoet E.E.J., Goetsch W.G. Antibiotic use and resistance of Streptococcus pneumoniae in the Netherlands 1994-1999. J. Antimicrob. Chemother. 48:2001;441-444.
51. Syrogiannopoulos G., Grivea J.N., Davies T.A., et al. Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin. Infect. Dis. 31:2000;887-893.
52. Goosens H, Lammens C, Lontic M, et al. Streptococcus pyogenes (S py) resistance to erythromycin (ERY) in relation to mechanisms of resistance, genotype and consumption of macrolides (M). Abstract C2-1314. Abstracts of the 41th Interscience Conference of Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 2001.
53. Melo-Cristino J, Fernandes ML, The Portuguese Surveillance Group for the Study of Respiratory Pathogens. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Microb Drug Resist 1999;5:219-25.
54. Cornaglia G., Huovinen P. Macrolide resistance in Streptococcus pyogenes in Europe. APUA Newsl. 16:1998;1-3.
55. nd international congress of Chemotherapy, Amsterdam, The Netherlands. Int J Antimicrob Agents 2001; 17 (Suppl 1): 132.
56. Adam D., Scholz H., Helmerking M. Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae. J. Infect. Dis. 182:2000;509-516.
57. Bozdogan B, Stratchounski LS, Kozlov RS, et al. Mechanisms of erythromycin. A resistance in S. pneumoniae and S. pyogenes isolates from Russia. Abstract C1-163. Abstract of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 2001.
58. Baquero F. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J. Chemother. 11:(Suppl 1):1999;35-43.
59. Cizman M., Paragi M., Jovan-Kuhar N., et al. Antimicrobial resistance of invasive Streptococcus pneumoanie in Slovenia, 1993-1995. Scand. J. Infect. Dis. 29:1997;251-254.
60. Arvand M., Hoeck M., Hahn H., Wagner J. Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin. J. Antimicrob. Chemother. 46:2000;621-624.
61. Turnidge J.D., Bell J.M., Collignon P.J. Rapidly emerging antimicrobial resistance in Streptococcus pneumoniae in Australia. Pneumococcal study group. Med. J. Aust. 170:1999;152-155.
62. Roussel-Delvallez M., Chardon H., Dupont H.J., et al. Change of pneumococcal resistance to antibiotics in adults between 1995 and 1997: a study in eight French counties. Int. J. Antimicrob. Agents. 19:2002;389-396.
63. Chen DK, McGeer A, De Azavedo JC, Low DE, Canadian Bacterial surveillance network. Decreased susceptibility of Streptococcus pneumoniae to fluroquinolones in Canada. N Engl J Med 1999;341:233-9.
64. Linares J., De La Campa A., Pallares R. Fluoroquinolone resistance in Streptococcus pneumoniae. N. Engl. J. Med. 341:1999;1546-1547.
65. Goetsch W., Van Pelt W., Nagelkerke N., et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J. Antimicrob. Chemother. 46:2000;223-228.
66. Cizman M., Orazem M., Krizan-Hergouth V., Kolman J. Correlations between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli urinary tract infection. J. Antimicrob. Chemother. 47:2001;502.
67. Martin J.N., Rose D.A., Hadley Wk, Perdrean-Reemington F., Lam P.K., Gerberding J.L. Emergence of trimethophrim-sulfamethoxazole resistance in the AIDS era. J. Infect. Dis. 180:1999;1809-1818.
68. Fujito K., Murono K., Yoshikawa M., Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr. Infect. Dis. J. 13:1994;1075-1078.
69. Seppäla H., Klankka T., Vuopio-Varkula J., et al. The effect of changes in the consumption of macrolide antibiotics and erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337:1997;441-446.
70. Kristinston KG, Hjalmarsdoltir MA, Gudnason KG. Continued decline in the incidence of penicillin nonsusceptible pneumococci in Iceland. Abstract C-22. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 1998.
71. Kristinsson K.G. Mathematical models as tools for evaluating the effectiveness of interventions: a comment on Levin. Clin. Infect. Dis. 33:(Suppl 3):2001;S174-S179.
72. Enne V.I., Livermore D.M., Strephens P., Hall L.M.C. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet. 357:2001;1325.
73. Guillemot D., Carbon C., Balkan B., et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin resistant Streptococcus pneumoniae. JAMA. 279:1998;365-370.
74. Cohen R., Reinert P., De La Rocque F., et al. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr. Infect. Dis. J. 21:2002;297-303.
75. Marchese A., Debbia A., Arvige A., Pesce A., Schito G.C. Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and other antibiotics. J. Antimicrob. Chemother. 36:1995;833-837.
76. Huchon G.J., Gialdroni-Grassi G., Leophonte P., Manresa F., Schaberg T., Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur. Respir. J. 9:1996;1590-1595.
77. Cohen R., Bingen E., Varon E., et al. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr. Infect. Dis. J. 16:1997;555-560.
78. Drusano G.I., Johnson D.E., Rosen M., Standiford H.C. Pharmacodynamic of a fluroquinolone antimicrobial agent in a neutropenic model of Pseudomonas sepsis. Antimicrob. Agents Chemother. 37:1993;483-490.
79. Blaser J., Stone B.B., Groner M.C., Zinner S.M. Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob. Agents Chemother. 31:1987;1054-1060.
80. Craig W.A. Does the dose matter? Clin. Infect. Dis. 33:(Suppl 3):2001;S233-S237.
81. Dagan R., Johnson C.E., McLinn S., et al. Bacteriologic and clinical efficacy of amoxycillin/clavulanate vs azithromycin in acute otitis media. Pediatr. Infect. Dis. J. 19:2000;95-104.
82. Dong Y., Zhao X., Domagala J., Drlica K. Effect of fluoroquionolone concentration on selection of resistant mutant of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob. Agents Chemother. 43:1999;1756-1758.
83. Zhao X., Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolones studies. Clin. Infect. Dis. 33:(Suppl 3):2001;S147-S156.
84. Blondeau J., Zhao X., Hansen G., Drlica K. Mutant prevention concentration (MPC) as a guide for treating Streptococcus pneumoniae with fluoroquinolones. Antimicrob. Agents Chemother. 45:2001;433-438.
85. Tenover F.C., McGowan J.E. Jr. Reasons for the emergence of antibiotic resistance. Am. J. Med. Sci. 311:1996;9-16.
86. Munoz R., Coffey T.I., Darriels M., et al. Intercontinental spread of a multiresistant clone of serotype 23 F Streptococcus pneumoniae. J. Infect. Dis. 164:1991;302-306.
87. Soares S., Kristinsson K.G., Musser J.M., Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J. Infect. Dis. 168:1993;158-163.
88. Lynch J.P. III, Martinez F.J. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin. Infect. Dis. 34:(Suppl 1):2002;S27-S46.
89. Schrag S.J., Beall B., Dowell S.F. Limiting spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin. Microbiol. Rev. 13:2000;588-601.
90. Richter SS, Heilmann, Coffman SL, Huynh HK, Pfaller MA, Doern GV. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Abstract C2-696. Abstract of the 41st Interscience Conference of Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology; 2001.
91. Martin J.M., Green M., Buarbadora K.A., Wald E.R. Erythromycin-resistant group A streptococci in school children in Pittsburgh. N. Engl. J. Med. 346:2002;1200-1206.
92. Manges A.R., Johnson J.R., Foxman B., O'Bryan T., Fullerton K.F., Riley L.W. Widespread distribution of urinary tract infection caused a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 345:2001;1007-1013.
93. Pechere J.C. Patient's interviews and misuse of antibiotics. Clin. Infect. Dis. 33:(Suppl 3):2001;S170-S173.
94. Branthwaite A., Pechere J.C. Pan-European survey of patients' attitudes to antibiotics and antibiotic use. J. Int. Med. Res. 24:1996;229-238.
95. McFarlane J., Holmes W., McFarlane R., Britten N. Influence of patient's expectations on antibiotic management of acute lower respiratory tract: illness in general practice: questionnaire study. Brit. Med. J. 315:1997;1211-1214.
96. Bauchner H., Pelton S.I., Klein J.O. Parents, physicians and antibiotic use. Pediatrics. 103:1999;395-398.